Fenretinide binding to the lysosomal protein saposin D alters ceramide solubilization and hydrolysis

Brandon T. Milliken; Lindy Melegari; Gideon L. Smith; Kris Grohn; Aaron J. Wolfe; Kelsey Moody; Fadi Bou-Abdallah; Robert P. Doyle

doi:10.1039/d0md00182a

Fenretinide binding to the lysosomal protein saposin D alters ceramide solubilization and hydrolysis

Brandon T. Milliken
, Lindy Melegari
, Gideon L. Smith
, Kris Grohn
, Aaron J. Wolfe
, Kelsey Moody
, Fadi Bou-Abdallah
, Robert P. Doyle

Research output: Contribution to journal › Article › peer-review

Abstract

Fenretinide is a synthetic retinoid pharmaceutical linked to ceramide build-up in vivo. Saposin D is an intralysosomal protein necessary for ceramide binding/degradation. We show, via electronic absorption spectroscopy, fluorescence spectroscopy, and ceramide hydrolysis assays, that fenretinide is bound by saposin D {Ka = (1.45 ± 0.49) × 105 M-1}, and affects ceramide solubilization/degradation.

Original language	English
Pages (from-to)	1048-1052
Number of pages	5
Journal	RSC Medicinal Chemistry
Volume	11
Issue number	9
DOIs	https://doi.org/10.1039/d0md00182a
State	Published - Sep 2020

Access to Document

10.1039/d0md00182a

Cite this

@article{ea1a01421564453599ae6e831d8f0e97,

title = "Fenretinide binding to the lysosomal protein saposin D alters ceramide solubilization and hydrolysis",

abstract = "Fenretinide is a synthetic retinoid pharmaceutical linked to ceramide build-up in vivo. Saposin D is an intralysosomal protein necessary for ceramide binding/degradation. We show, via electronic absorption spectroscopy, fluorescence spectroscopy, and ceramide hydrolysis assays, that fenretinide is bound by saposin D \{Ka = (1.45 ± 0.49) × 105 M-1\}, and affects ceramide solubilization/degradation.",

author = "Milliken, \{Brandon T.\} and Lindy Melegari and Smith, \{Gideon L.\} and Kris Grohn and Wolfe, \{Aaron J.\} and Kelsey Moody and Fadi Bou-Abdallah and Doyle, \{Robert P.\}",

note = "Publisher Copyright: {\textcopyright} 2020 The Royal Society of Chemistry.",

year = "2020",

month = sep,

doi = "10.1039/d0md00182a",

language = "English",

volume = "11",

pages = "1048--1052",

journal = "RSC Medicinal Chemistry",

number = "9",

}

TY - JOUR

T1 - Fenretinide binding to the lysosomal protein saposin D alters ceramide solubilization and hydrolysis

AU - Milliken, Brandon T.

AU - Melegari, Lindy

AU - Smith, Gideon L.

AU - Grohn, Kris

AU - Wolfe, Aaron J.

AU - Moody, Kelsey

AU - Bou-Abdallah, Fadi

AU - Doyle, Robert P.

PY - 2020/9

Y1 - 2020/9

N2 - Fenretinide is a synthetic retinoid pharmaceutical linked to ceramide build-up in vivo. Saposin D is an intralysosomal protein necessary for ceramide binding/degradation. We show, via electronic absorption spectroscopy, fluorescence spectroscopy, and ceramide hydrolysis assays, that fenretinide is bound by saposin D {Ka = (1.45 ± 0.49) × 105 M-1}, and affects ceramide solubilization/degradation.

AB - Fenretinide is a synthetic retinoid pharmaceutical linked to ceramide build-up in vivo. Saposin D is an intralysosomal protein necessary for ceramide binding/degradation. We show, via electronic absorption spectroscopy, fluorescence spectroscopy, and ceramide hydrolysis assays, that fenretinide is bound by saposin D {Ka = (1.45 ± 0.49) × 105 M-1}, and affects ceramide solubilization/degradation.

UR - https://www.scopus.com/pages/publications/85091867488

U2 - 10.1039/d0md00182a

DO - 10.1039/d0md00182a

M3 - Article

VL - 11

SP - 1048

EP - 1052

JO - RSC Medicinal Chemistry

JF - RSC Medicinal Chemistry

IS - 9

ER -

Fenretinide binding to the lysosomal protein saposin D alters ceramide solubilization and hydrolysis

Abstract

Access to Document

Other files and links

Fingerprint

Cite this